Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 2635

1.

Callosal agenesis and congenital mirror movements: outcomes associated with DCC mutations.

Spencer-Smith M, Knight JL, Lacaze E; Irc5 Consortium, Depienne C, Lockhart PJ, Richards LJ, Heron D, Leventer RJ, Robinson GA.

Dev Med Child Neurol. 2020 Feb 14. doi: 10.1111/dmcn.14486. [Epub ahead of print]

PMID:
32060908
2.

Indirectly Activated Treg Allow Dominant Tolerance to Murine Skin-grafts Across an MHC Class I Mismatch After a Single Donor Specific Transfusion.

Zhang GY, Hu M, Watson D, Wang YM, Knight JF, Alexander SI.

Transplantation. 2020 Feb 12. doi: 10.1097/TP.0000000000003173. [Epub ahead of print]

PMID:
32053573
3.

Acute diabetes complications across transition from pediatric to adult care in Ontario and Newfoundland and Labrador: a population-based cohort study.

Shulman R, Fu L, Knight JC, Guttmann A, Chafe R.

CMAJ Open. 2020 Feb 11;8(1):E69-E74. doi: 10.9778/cmajo.20190019. Print 2020 Jan-Mar.

4.

Protocol for a multi-centre, definitive randomised controlled trial of the effectiveness of Individual Placement and Support for employment support among people with alcohol and drug dependence.

Marsden J, Anders P, Clark H, Colocassis K, Eastwood B, Knight J, Melaugh A, Quinn D, Wright V, Stannard J.

Trials. 2020 Feb 11;21(1):167. doi: 10.1186/s13063-020-4099-4.

5.

Peripheral CD8+ T cell characteristics associated with durable responses to immune checkpoint blockade in patients with metastatic melanoma.

Fairfax BP, Taylor CA, Watson RA, Nassiri I, Danielli S, Fang H, Mahé EA, Cooper R, Woodcock V, Traill Z, Al-Mossawi MH, Knight JC, Klenerman P, Payne M, Middleton MR.

Nat Med. 2020 Feb;26(2):193-199. doi: 10.1038/s41591-019-0734-6. Epub 2020 Feb 10.

PMID:
32042196
6.

Digital ischaemia secondary to adalimumab-induced antiphospholipid syndrome.

Cheemalavagu S, McCoy SS, Knight JS.

BMJ Case Rep. 2020 Feb 9;13(2). pii: e232907. doi: 10.1136/bcr-2019-232907.

PMID:
32041760
7.

Community nutrition nurse specialist role: a service improvement.

Knight J.

Br J Community Nurs. 2020 Feb 2;25(2):76-81. doi: 10.12968/bjcn.2020.25.2.76.

PMID:
32040359
8.

Assessment of an Antibody-in-Lymphocyte Supernatant Assay for the Etiological Diagnosis of Pneumococcal Pneumonia in Children.

Carter MJ, Gurung P, Jones C, Rajkarnikar S, Kandasamy R, Gurung M, Thorson S, Gautam MC, Prajapati KG, Khadka B, Maharjan A, Knight JC, Murdoch DR, Darton TC, Voysey M, Wahl B, O'Brien KL, Kelly S, Ansari I, Shah G, Ekström N, Melin M, Pollard AJ, Kelly DF, Shrestha S.

Front Cell Infect Microbiol. 2020 Jan 17;9:459. doi: 10.3389/fcimb.2019.00459. eCollection 2019.

9.

Propranolol inhibits molecular risk markers in HCT recipients: a phase 2 randomized controlled biomarker trial.

Knight JM, Rizzo JD, Hari P, Pasquini MC, Giles KE, D'Souza A, Logan BR, Hamadani M, Chhabra S, Dhakal B, Shah N, Sriram D, Horowitz MM, Cole SW.

Blood Adv. 2020 Feb 11;4(3):467-476. doi: 10.1182/bloodadvances.2019000765.

10.

Alcohol use and mental health symptoms in female firefighter recruits.

Gulliver SB, Zimering RT, Dobani F, Pennington ML, Morissette SB, Kamholz BW, Knight JA, Keane TM, Kimbrel NA, Carpenter TP, Meyer EC.

Occup Med (Lond). 2019 Dec 31;69(8-9):625-631. doi: 10.1093/occmed/kqaa015.

PMID:
32025738
11.

APOE4 exacerbates α-synuclein pathology and related toxicity independent of amyloid.

Zhao N, Attrebi ON, Ren Y, Qiao W, Sonustun B, Martens YA, Meneses AD, Li F, Shue F, Zheng J, Van Ingelgom AJ, Davis MD, Kurti A, Knight JA, Linares C, Chen Y, Delenclos M, Liu CC, Fryer JD, Asmann YW, McLean PJ, Dickson DW, Ross OA, Bu G.

Sci Transl Med. 2020 Feb 5;12(529). pii: eaay1809. doi: 10.1126/scitranslmed.aay1809.

PMID:
32024798
12.

Unusual Mechanisms of Penile Amputation.

Fazi J, Adkins D, Knight J, Luchey A.

Case Rep Urol. 2019 Dec 26;2019:1582047. doi: 10.1155/2019/1582047. eCollection 2019.

13.

Traumatic Bladder Ruptures: A Ten-Year Review at a Level 1 Trauma Center.

Barnard J, Overholt T, Hajiran A, Crigger C, Jessop M, Knight J, Morley C.

Adv Urol. 2019 Dec 12;2019:2614586. doi: 10.1155/2019/2614586. eCollection 2019.

14.

Future treatments for hyperoxaluria.

Burns Z, Knight J, Fargue S, Holmes R, Assimos D, Wood K.

Curr Opin Urol. 2020 Mar;30(2):171-176. doi: 10.1097/MOU.0000000000000709.

PMID:
31895888
15.

The Use of Whole Exome Sequencing in a Cohort of Transgender Individuals to Identify Rare Genetic Variants.

Theisen JG, Sundaram V, Filchak MS, Chorich LP, Sullivan ME, Knight J, Kim HG, Layman LC.

Sci Rep. 2019 Dec 27;9(1):20099. doi: 10.1038/s41598-019-53500-y.

16.

Preventive Pharmacotherapy for Cardiovascular Disease: A Modelling Study Considering Health Gain, Costs, and Cost-Effectiveness when Stratifying by Absolute Risk.

Nghiem N, Knight J, Mizdrak A, Blakely T, Wilson N.

Sci Rep. 2019 Dec 20;9(1):19562. doi: 10.1038/s41598-019-55372-8.

17.

Early Detection in a Mouse Model of Pancreatic Cancer by Imaging DNA Damage Response Signalling.

Knight JC, Baguna Torres J, Goldin R, Mosley M, Dias GM, Contreras Bravo L, Kersemans V, Allen PD, Mukherjee S, Smart SC, Cornelissen B.

J Nucl Med. 2019 Dec 20. pii: jnumed.119.234708. doi: 10.2967/jnumed.119.234708. [Epub ahead of print]

PMID:
31862800
18.

Correction: BRF1 accelerates prostate tumourigenesis and perturbs immune infiltration.

Loveridge CJ, Slater S, Campbell KJ, Nam NA, Knight J, Ahmad I, Hedley A, Lilla S, Repiscak P, Patel R, Salji M, Fleming J, Mitchell L, Nixon C, Strathdee D, Neilson M, Ntala C, Bryson S, Zanivan S, Edwards J, Robson CN, Goodyear CS, Blyth K, Leung HY.

Oncogene. 2019 Dec 19. doi: 10.1038/s41388-019-1149-z. [Epub ahead of print]

PMID:
31857667
19.

Accuracy of Risk Estimates from the iPrevent Breast Cancer Risk Assessment and Management Tool.

Phillips KA, Liao Y, Milne RL, MacInnis RJ, Collins IM, Buchsbaum R, Weideman PC, Bickerstaffe A, Nesci S, Chung WK, Southey MC, Knight JA, Whittemore AS, Dite GS, Goldgar D, Giles GG, Glendon G, Cuzick J, Antoniou AC, Andrulis IL, John EM, Daly MB, Buys SS, Hopper JL, Terry MB; kConFab Investigators.

JNCI Cancer Spectr. 2019 Sep 19;3(4):pkz066. doi: 10.1093/jncics/pkz066. eCollection 2019 Dec.

20.

Association between maternal acetaminophen use and adverse birth outcomes in a pregnancy and birth cohort.

Arneja J, Hung RJ, Seeto RA, Knight JA, Hewko SL, Bocking A, Lye SJ, Brooks JD.

Pediatr Res. 2019 Dec 18. doi: 10.1038/s41390-019-0726-8. [Epub ahead of print]

PMID:
31852009
21.

Use of gene expression studies to investigate the human immunological response to malaria infection.

Hodgson SH, Muller J, Lockstone HE, Hill AVS, Marsh K, Draper SJ, Knight JC.

Malar J. 2019 Dec 13;18(1):418. doi: 10.1186/s12936-019-3035-0. Review.

22.

The effects of the inactivation of Hydroxyproline dehydrogenase on urinary oxalate and glycolate excretion in mouse models of primary hyperoxaluria.

Buchalski B, Wood KD, Challa A, Fargue S, Holmes RP, Lowther WT, Knight J.

Biochim Biophys Acta Mol Basis Dis. 2020 Mar 1;1866(3):165633. doi: 10.1016/j.bbadis.2019.165633. Epub 2019 Dec 7.

PMID:
31821850
23.

A new chiral boron-dipyrromethene (BODIPY)-based fluorescent probe: molecular docking, DFT, antibacterial and antioxidant approaches.

Alnoman RB, Parveen S, Hagar M, Ahmed HA, Knight JG.

J Biomol Struct Dyn. 2019 Dec 19:1-14. doi: 10.1080/07391102.2019.1701555. [Epub ahead of print]

PMID:
31809642
24.

Pediatric antiphospholipid syndrome.

Madison JA, Zuo Y, Knight JS.

Eur J Rheumatol. 2019 Dec 3:1-10. doi: 10.5152/eurjrheum.2019.19160. [Epub ahead of print] Review.

25.

Burnout among behavioral health providers in integrated care settings.

Zubatsky M, Runyan C, Gulotta S, Knight JR, Pettinelli JD.

Fam Syst Health. 2019 Dec 2. doi: 10.1037/fsh0000456. [Epub ahead of print]

PMID:
31789532
26.

Detection of Stress Induced by Soybean Aphid (Hemiptera: Aphididae) Using Multispectral Imagery from Unmanned Aerial Vehicles.

Marston ZPD, Cira TM, Hodgson EW, Knight JF, Macrae IV, Koch RL.

J Econ Entomol. 2019 Nov 29. pii: toz306. doi: 10.1093/jee/toz306. [Epub ahead of print]

PMID:
31782504
27.

Alcohol consumption, cigarette smoking, and familial breast cancer risk: findings from the Prospective Family Study Cohort (ProF-SC).

Zeinomar N, Knight JA, Genkinger JM, Phillips KA, Daly MB, Milne RL, Dite GS, Kehm RD, Liao Y, Southey MC, Chung WK, Giles GG, McLachlan SA, Friedlander ML, Weideman PC, Glendon G, Nesci S; kConFab Investigators, Andrulis IL, Buys SS, John EM, MacInnis RJ, Hopper JL, Terry MB.

Breast Cancer Res. 2019 Nov 28;21(1):128. doi: 10.1186/s13058-019-1213-1.

28.

Soft X-ray spectroscopy with transition-edge sensors at Stanford Synchrotron Radiation Lightsource beamline 10-1.

Lee SJ, Titus CJ, Alonso Mori R, Baker ML, Bennett DA, Cho HM, Doriese WB, Fowler JW, Gaffney KJ, Gallo A, Gard JD, Hilton GC, Jang H, Joe YI, Kenney CJ, Knight J, Kroll T, Lee JS, Li D, Lu D, Marks R, Minitti MP, Morgan KM, Ogasawara H, O'Neil GC, Reintsema CD, Schmidt DR, Sokaras D, Ullom JN, Weng TC, Williams C, Young BA, Swetz DS, Irwin KD, Nordlund D.

Rev Sci Instrum. 2019 Nov 1;90(11):113101. doi: 10.1063/1.5119155.

PMID:
31779391
29.

Molecular Correlates of Socioeconomic Status and Clinical Outcomes Following Hematopoietic Cell Transplantation for Leukemia.

Knight JM, Rizzo JD, Wang T, He N, Logan BR, Spellman SR, Lee SJ, Verneris MR, Arevalo JMG, Cole SW.

JNCI Cancer Spectr. 2019 Sep 12;3(4):pkz073. doi: 10.1093/jncics/pkz073. eCollection 2019 Dec.

30.

Through the Eyes of Faculty: Using Personas as a Tool for Learner-Centered Professional Development.

Zagallo P, McCourt J, Idsardi R, Smith MK, Urban-Lurain M, Andrews TC, Haudek K, Knight JK, Merrill J, Nehm R, Prevost LB, Lemons PP.

CBE Life Sci Educ. 2019 Dec;18(4):ar62. doi: 10.1187/cbe.19-06-0114.

31.

Combined 400-600nm and 800-1200nm Intense Pulsed Phototherapy of Facial Acne Vulgaris

Knight JM.

J Drugs Dermatol. 2019 Nov 1;18(11):1116-1122.

PMID:
31741354
32.

BRF1 accelerates prostate tumourigenesis and perturbs immune infiltration.

Loveridge CJ, Slater S, Campbell KJ, Nam NA, Knight J, Ahmad I, Hedley A, Lilla S, Repiscak P, Patel R, Salji M, Fleming J, Mitchell L, Nixon C, Strathdee D, Neilson M, Ntala C, Bryson S, Zanivan S, Edwards J, Robson CN, Goodyear CS, Blyth K, Leung HY.

Oncogene. 2020 Feb;39(8):1797-1806. doi: 10.1038/s41388-019-1106-x. Epub 2019 Nov 18. Erratum in: Oncogene. 2019 Dec 19;:.

PMID:
31740786
33.

Genomic sites hypersensitive to ultraviolet radiation.

Premi S, Han L, Mehta S, Knight J, Zhao D, Palmatier MA, Kornacker K, Brash DE.

Proc Natl Acad Sci U S A. 2019 Nov 26;116(48):24196-24205. doi: 10.1073/pnas.1907860116. Epub 2019 Nov 13.

PMID:
31723047
34.

Disruption of Neutrophil Extracellular Traps (NETs) Links Mechanical Strain to Post-traumatic Inflammation.

Agarwal S, Loder SJ, Cholok D, Li J, Bian G, Yalavarthi S, Li S, Carson WF, Hwang C, Marini S, Pagani C, Edwards N, Delano MJ, Standiford TJ, Knight JS, Kunkel SL, Mishina Y, Ward PA, Levi B.

Front Immunol. 2019 Oct 24;10:2148. doi: 10.3389/fimmu.2019.02148. eCollection 2019.

35.

Understanding Lung Cancer Resources and Barriers Among Worksites With Mostly Male Employees in Eight Rural Kentucky Counties: A Focus Group Discussion.

Knight JR, Williamson LH, Armstrong DK, Westbrook EA.

Am J Mens Health. 2019 Nov-Dec;13(6):1557988319882585. doi: 10.1177/1557988319882585.

36.

A MYC-GCN2-eIF2α negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer.

Schmidt S, Gay D, Uthe FW, Denk S, Paauwe M, Matthes N, Diefenbacher ME, Bryson S, Warrander FC, Erhard F, Ade CP, Baluapuri A, Walz S, Jackstadt R, Ford C, Vlachogiannis G, Valeri N, Otto C, Schülein-Völk C, Maurus K, Schmitz W, Knight JRP, Wolf E, Strathdee D, Schulze A, Germer CT, Rosenwald A, Sansom OJ, Eilers M, Wiegering A.

Nat Cell Biol. 2019 Nov;21(11):1413-1424. doi: 10.1038/s41556-019-0408-0. Epub 2019 Nov 4.

PMID:
31685988
37.

Posterior Reversible Encephalopathy Syndrome Instigated by Off-Label Disulfiram Use for Metastatic Melanoma.

Beam DR, Knight JM.

Psychosomatics. 2019 Sep 17. pii: S0033-3182(19)30191-4. doi: 10.1016/j.psym.2019.09.003. [Epub ahead of print] No abstract available.

PMID:
31668552
38.

Correlations between genomic subgroup and clinical features in a cohort of more than 3000 meningiomas.

Youngblood MW, Duran D, Montejo JD, Li C, Omay SB, Özduman K, Sheth AH, Zhao AY, Tyrtova E, Miyagishima DF, Fomchenko EI, Hong CS, Clark VE, Riche M, Peyre M, Boetto J, Sohrabi S, Koljaka S, Baranoski JF, Knight J, Zhu H, Pamir MN, Avşar T, Kilic T, Schramm J, Timmer M, Goldbrunner R, Gong Y, Bayri Y, Amankulor N, Hamilton RL, Bilguvar K, Tikhonova I, Tomak PR, Huttner A, Simon M, Krischek B, Kalamarides M, Erson-Omay EZ, Moliterno J, Günel M.

J Neurosurg. 2019 Oct 25:1-10. doi: 10.3171/2019.8.JNS191266. [Epub ahead of print]

PMID:
31653806
39.

On the Mechanism of the Asymmetric Aldol Addition of Chiral N-Amino Cyclic Carbamate Hydrazones: Evidence of Non-Curtin-Hammett Behavior.

Uddin MN, Knight JD, Rastelli EJ, Soubra-Ghaoui C, Albright TA, Wu CH, Wu JI, Coltart DM.

Chemistry. 2019 Oct 25. doi: 10.1002/chem.201902388. [Epub ahead of print]

PMID:
31650641
40.

Opioid use prior to elective surgery is strongly associated with persistent use following surgery: an analysis of 14 354 Medicare patients.

Catchpool M, Knight J, Young JT, Clarke P, Barrington MJ, Choong PFM, Dowsey MM.

ANZ J Surg. 2019 Nov;89(11):1410-1416. doi: 10.1111/ans.15492. Epub 2019 Oct 21.

41.

Skin infections in Australian Aboriginal children: a narrative review.

Davidson L, Knight J, Bowen AC.

Med J Aust. 2019 Oct 20. doi: 10.5694/mja2.50361. [Epub ahead of print] Review.

PMID:
31630410
42.

Properties of Stress Granule and P-Body Proteomes.

Youn JY, Dyakov BJA, Zhang J, Knight JDR, Vernon RM, Forman-Kay JD, Gingras AC.

Mol Cell. 2019 Oct 17;76(2):286-294. doi: 10.1016/j.molcel.2019.09.014. Review.

PMID:
31626750
43.

Extracellular Trap-Mimicking DNA-Histone Mesostructures Synergistically Activate Dendritic Cells.

Weerappuli PD, Louttit C, Kojima T, Brennan L, Yalavarthi S, Xu Y, Ochyl LJ, Maeda ML, Kim HS, Knight JS, Takayama S, Moon JJ.

Adv Healthc Mater. 2019 Nov;8(22):e1900926. doi: 10.1002/adhm.201900926. Epub 2019 Oct 15.

PMID:
31614077
44.

Population-Level Sexual Mixing By HIV Status and Pre-exposure Prophylaxis Use Among Men Who Have Sex with Men in Montreal, Canada: Implications for HIV Prevention.

Wang L, Moqueet N, Lambert G, Grace D, Rodrigues R, Cox J, Lachowsky NJ, Noor SW, Armstrong HL, Tan DHS, Burchell AN, Ma H, Apelian H, Knight J, Messier-Peet M, Jollimore J, Baral S, Hart TA, Moore DM, Mishra S.

Am J Epidemiol. 2019 Oct 15. pii: kwz231. doi: 10.1093/aje/kwz231. [Epub ahead of print]

PMID:
31612213
45.

The Glucocorticoid Receptor in Cardiovascular Health and Disease.

Liu B, Zhang TN, Knight JK, Goodwin JE.

Cells. 2019 Oct 9;8(10). pii: E1227. doi: 10.3390/cells8101227. Review.

46.

Threshold concepts: A portal into new ways of thinking and practising in psychiatry.

Khatri R, Knight J, Wilkinson I.

Med Teach. 2020 Feb;42(2):178-186. doi: 10.1080/0142159X.2019.1670338. Epub 2019 Oct 10.

PMID:
31599178
47.

S-Nitrosylation of CHIP Enhances F508Del-CFTR Maturation.

Zaman K, Knight J, Hussain F, Cao R, Estabrooks SK, Altawallbeh G, Holloway K, Jafri A, Sawczak V, Li Y, Getsy P, Sun F, Raffay T, Cotton C, Brodsky JL, Periasamy A, Lewis SJ, Gaston B.

Am J Respir Cell Mol Biol. 2019 Dec;61(6):765-775. doi: 10.1165/rcmb.2018-0314OC.

PMID:
31596601
48.

Context-specific regulation of surface and soluble IL7R expression by an autoimmune risk allele.

Al-Mossawi H, Yager N, Taylor CA, Lau E, Danielli S, de Wit J, Gilchrist J, Nassiri I, Mahe EA, Lee W, Rizvi L, Makino S, Cheeseman J, Neville M, Knight JC, Bowness P, Fairfax BP.

Nat Commun. 2019 Oct 8;10(1):4575. doi: 10.1038/s41467-019-12393-1.

49.

Medicines associated with dependence or withdrawal: a mixed-methods public health review and national database study in England.

Marsden J, White M, Annand F, Burkinshaw P, Carville S, Eastwood B, Kelleher M, Knight J, O'Connor R, Tran A, Willey P, Greaves F, Taylor S.

Lancet Psychiatry. 2019 Nov;6(11):935-950. doi: 10.1016/S2215-0366(19)30331-1. Epub 2019 Oct 3. Review.

50.

Considerations when using breast cancer risk models for women with negative BRCA1/BRCA2 mutation results.

MacInnis RJ, Liao Y, Knight JA, Milne RL, Whittemore AS, Chung WK, Leoce N, Buchsbaum R, Zeinomar N, Dite GS, Southey MC, Goldgar D, Giles GG, McLachlan SA, Weideman PC, Nesci S, Friedlander ML, Glendon G; kConFab Investigators, Andrulis IL, John EM, Daly MB, Buys SS, Phillips KA, Hopper JL, Terry MB.

J Natl Cancer Inst. 2019 Oct 4. pii: djz194. doi: 10.1093/jnci/djz194. [Epub ahead of print]

PMID:
31584660

Supplemental Content

Loading ...
Support Center